Evidence map›Paper›PMID 22198955›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Importance of antibody in virus infection and vaccine-mediated protection by a latency-deficient recombinant murine γ-herpesvirus-68.

Michael L Freeman, Claire E Burkum, David L Woodland, Ren Sun, Ting-Ting Wu, Marcia A Blackman

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michael L FreemanTrudeau Institute, Saranac Lake, NY 12983, USA.
Claire E Burkum
David L Woodland
Ren Sun
Ting-Ting Wu
Marcia A Blackman
Trudeau Institute · USLos Angeles Medical Center · US

Funding

ORF36 Viral Kinase as a Transcriptional Regulator of KSHVP01DE019085 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2008 to 2012
$6.4M
T CELL IMMUNITY TO MHV 68, A MURINE GAMMA HERPEVIRUSR01AI042927 · NIAID · TRUDEAU INSTITUTE, INC. · PI BLACKMAN, MARCIA A · 1998 to 2008
$2.5M
Research Training in Immunology and Infectious DiseasesT32AI049823 · NIAID · TRUDEAU INSTITUTE, INC. · PI COOPER, ANDREA M · 2001 to 2015
$2.1M
Immunogenicity and efficacy of genetically engineered gamma-herpesvirus vaccinesRC2CA148250 · NCI · TRUDEAU INSTITUTE, INC. · PI BLACKMAN, MARCIA A, SUN, REN · 2009 to 2010
$1000k
Can persistent gamma-herpesviruses be purged from the host?R21AI082919 · NIAID · TRUDEAU INSTITUTE, INC. · PI BLACKMAN, MARCIA A · 2009 to 2010
$502k
CD* T cell responses to gamma-herpesviral infectionF32AI084327 · NIAID · TRUDEAU INSTITUTE, INC. · PI FREEMAN, MICHAEL L · 2009 to 2010
$98k
NCI NIH HHS CA148250NCI NIH HHS RC2 CA148250NIAID NIH HHS AI042927NIAID NIH HHS AI049823NIAID NIH HHS AI082919NIAID NIH HHS AI084327NIAID NIH HHS F32 AI084327NIAID NIH HHS R01 AI042927NIAID NIH HHS R21 AI082919NIAID NIH HHS T32 AI049823NIDCR NIH HHS DE019085NIDCR NIH HHS P01 DE019085
6 · The paper itself

Abstract

The human γ-herpesviruses EBV and Kaposi's sarcoma-associated herpesvirus establish lifelong latent infections, can reactivate in immunocompromised individuals, and are associated with the development of malignancies. Murine γ-herpesvirus-68 (γHV68), a rodent pathogen related to EBV and Kaposi's sarcoma-associated herpesvirus, provides an important model to dissect mechanisms of immune control and investigate vaccine strategies. Infection of mice with γHV68 elicits robust antiviral immunity, and long-term protection from γHV68 reactivation requires both cellular and humoral immune responses. Vaccination of mice with AC-replication and transcription activator (RTA), a highly lytic latency-null recombinant γHV68, results in complete protection from wild-type γHV68 infection that lasts for at least 10 mo. In this report, we examine the immune correlates of AC-RTA-mediated protection and show that sterilizing immunity requires both T cells and Ab. Importantly, Ab was also critical for mitigating viral infection in the brain, and in the absence of Ab-mediated control, amplification of the AC-RTA virus in the brain resulted in fatality. Our results highlight important considerations in the development of vaccination strategies based on live-attenuated viruses.

Indexed as

Antibodies, ViralRhadinovirusVirus LatencyAnimalsImmunityMiceMice, Inbred C57BLT-LymphocytesVaccinationVaccinesVaccines, AttenuatedVirus ActivationVirus DiseasesAntibodies, ViralVaccinesVaccines, Attenuated

Identifiers

PMID22198955
PMCPMC3262927
OpenAlexW2101554533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.